EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Retained Earnings (2011 - 2026)

EyePoint (EYPT) posted Retained Earnings of -$1.2 billion for Q1 2026, down 7.68% sequentially from -$1.1 billion in Q4 2025, and down 29.58% YoY from -$1.7 billion in Q1 2025.

Analysis

EyePoint (EYPT) Retained Earnings (2011 - 2026) Analysis & Trends

EyePoint has reported Retained Earnings for 16 years, with the latest figure at -$1.2 billion in Q1 2026.

  • Quarterly Retained Earnings fell 29.58% year-over-year to -$1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 29.58% YoY) and the FY2025 annual result came in at -$1.1 billion, down 107588.13% from the prior year.
  • Retained Earnings slipped to -$1.2 billion in Q1 2026 per EYPT's latest filing, from -$1.1 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.2 million in Q3 2024 and troughed at -$1.2 billion in Q1 2026.
  • A 5-year average of -$538.5 million and a median of -$692.5 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings sank 111592.65% in 2023, then soared 100.16% in 2024.
  • Over 5 years, Retained Earnings stood at $786000.0 in 2022, then grew by 9.92% to $864000.0 in 2023, then grew by 18.98% to $1.0 million in 2024, then plunged by 107588.13% to -$1.1 billion in 2025, then slipped by 7.68% to -$1.2 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$1.2 billion, -$1.1 billion, and -$1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -1.28 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.28 Bn
Mar 31, 2026 -1.19 Bn
Dec 31, 2025 -1.10 Bn
Sep 30, 2025 -1.04 Bn
Jun 30, 2025 -977.64 Mn
Mar 31, 2025 -918.21 Mn
Dec 31, 2024 -873.02 Mn
Sep 30, 2024 -831.62 Mn
Jun 30, 2024 -802.26 Mn
Mar 31, 2024 -771.43 Mn
Dec 31, 2023 -742.15 Mn
Sep 30, 2023 -728.05 Mn
Jun 30, 2023 -715.44 Mn
Mar 31, 2023 -692.52 Mn
Dec 31, 2022 -671.35 Mn
Sep 30, 2022 -627.90 Mn
Jun 30, 2022 -609.48 Mn
Mar 31, 2022 -590.07 Mn
Dec 31, 2021 -569.10 Mn
Sep 30, 2021 -549.67 Mn